Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Chinese Medical Journal|June 16, 2021
A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in ChinaZhen-Yang Gu, Yu-Jun Dong, Xiao-Rui Fu, et al.
Journal of Hematology & Oncology|September 16, 2021
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 updateXiao-Hui Zhang, Jing Chen, Ming-Zhe Han, et al.
Bone Marrow Transplantation|August 26, 2021
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Pei-Hua Lu, De-Pei Wu, et al.
Blood|March 29, 2013
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trialHong-Hu Zhu, Xiao-Hui Zhang, Ya-Zhen Qin, et al.
Chinese Medical Journal|May 10, 2021
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 studyYuan-Kai Shi, Xiao-Nan Hong, Jian-Liang Yang, et al.
Transplantation and Cellular Therapy|November 19, 2022
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Dao-Pei Lu, De-Pei Wu, et al.
American Journal of Hematology|October 15, 2013
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: Results from a prospective, multi-center studyYu Wang, Wang Yu, Qi-Fa Liu, et al.
Bone Marrow Transplantation|September 25, 2024
Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Pei-Hua Lu, De-Pei Wu, et al.
Clinical Transplantation|October 26, 2025
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant RegistryXin Zhao, Ming Zhou, Bao-Dong Ye, et al.
Cancer Letters|March 29, 2025
Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: A CBMTR Registry-based propensity score matching analysis over the last decadeZheng-Li Xu, Yu-Ping Zhang, Bao-Dong Ye, et al.
Pageof 21